These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
340 related articles for article (PubMed ID: 25193021)
1. PRDX6 Exacerbates Dopaminergic Neurodegeneration in a MPTP Mouse Model of Parkinson's Disease. Yun HM; Choi DY; Oh KW; Hong JT Mol Neurobiol; 2015 Aug; 52(1):422-31. PubMed ID: 25193021 [TBL] [Abstract][Full Text] [Related]
2. The TrkB-positive dopaminergic neurons are less sensitive to MPTP insult in the substantia nigra of adult C57/BL mice. Ding YX; Xia Y; Jiao XY; Duan L; Yu J; Wang X; Chen LW Neurochem Res; 2011 Oct; 36(10):1759-66. PubMed ID: 21562748 [TBL] [Abstract][Full Text] [Related]
3. Kir6.1/K-ATP channel on astrocytes protects against dopaminergic neurodegeneration in the MPTP mouse model of Parkinson's disease via promoting mitophagy. Hu ZL; Sun T; Lu M; Ding JH; Du RH; Hu G Brain Behav Immun; 2019 Oct; 81():509-522. PubMed ID: 31288070 [TBL] [Abstract][Full Text] [Related]
4. Preferential Heme Oxygenase-1 Activation in Striatal Astrocytes Antagonizes Dopaminergic Neuron Degeneration in MPTP-Intoxicated Mice. Xu X; Song N; Wang R; Jiang H; Xie J Mol Neurobiol; 2016 Oct; 53(8):5056-65. PubMed ID: 26385576 [TBL] [Abstract][Full Text] [Related]
5. Dopamine receptor D3 expressed on CD4+ T cells favors neurodegeneration of dopaminergic neurons during Parkinson's disease. González H; Contreras F; Prado C; Elgueta D; Franz D; Bernales S; Pacheco R J Immunol; 2013 May; 190(10):5048-56. PubMed ID: 23589621 [TBL] [Abstract][Full Text] [Related]
6. The role of the MYD88-dependent pathway in MPTP-induced brain dopaminergic degeneration. Drouin-Ouellet J; Gibrat C; Bousquet M; Calon F; Kriz J; Cicchetti F J Neuroinflammation; 2011 Oct; 8():137. PubMed ID: 21989292 [TBL] [Abstract][Full Text] [Related]
7. Protective role of SIRT5 against motor deficit and dopaminergic degeneration in MPTP-induced mice model of Parkinson's disease. Liu L; Peritore C; Ginsberg J; Shih J; Arun S; Donmez G Behav Brain Res; 2015 Mar; 281():215-21. PubMed ID: 25541039 [TBL] [Abstract][Full Text] [Related]
8. miR-425 deficiency promotes necroptosis and dopaminergic neurodegeneration in Parkinson's disease. Hu YB; Zhang YF; Wang H; Ren RJ; Cui HL; Huang WY; Cheng Q; Chen HZ; Wang G Cell Death Dis; 2019 Aug; 10(8):589. PubMed ID: 31383850 [TBL] [Abstract][Full Text] [Related]
9. Genetic suppression of collapsin response mediator protein 2 phosphorylation improves outcome in methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's model mice. Togashi K; Hasegawa M; Nagai J; Tonouchi A; Masukawa D; Hensley K; Goshima Y; Ohshima T Genes Cells; 2019 Jan; 24(1):31-40. PubMed ID: 30375127 [TBL] [Abstract][Full Text] [Related]
10. Expression of S-100 protein is related to neuronal damage in MPTP-treated mice. Muramatsu Y; Kurosaki R; Watanabe H; Michimata M; Matsubara M; Imai Y; Araki T Glia; 2003 May; 42(3):307-13. PubMed ID: 12673835 [TBL] [Abstract][Full Text] [Related]
11. Neuroprotective effect of silymarin in a MPTP mouse model of Parkinson's disease. Pérez-H J; Carrillo-S C; García E; Ruiz-Mar G; Pérez-Tamayo R; Chavarría A Toxicology; 2014 May; 319():38-43. PubMed ID: 24607817 [TBL] [Abstract][Full Text] [Related]
13. α7 nicotinic acetylcholine receptor-mediated neuroprotection against dopaminergic neuron loss in an MPTP mouse model via inhibition of astrocyte activation. Liu Y; Hu J; Wu J; Zhu C; Hui Y; Han Y; Huang Z; Ellsworth K; Fan W J Neuroinflammation; 2012 May; 9():98. PubMed ID: 22624500 [TBL] [Abstract][Full Text] [Related]
14. Tauroursodeoxycholic acid prevents MPTP-induced dopaminergic cell death in a mouse model of Parkinson's disease. Castro-Caldas M; Carvalho AN; Rodrigues E; Henderson CJ; Wolf CR; Rodrigues CM; Gama MJ Mol Neurobiol; 2012 Oct; 46(2):475-86. PubMed ID: 22773138 [TBL] [Abstract][Full Text] [Related]
15. CX3CR1 Disruption Differentially Influences Dopaminergic Neuron Degeneration in Parkinsonian Mice Depending on the Neurotoxin and Route of Administration. Tristão FS; Lazzarini M; Martin S; Amar M; Stühmer W; Kirchhoff F; Gomes LA; Lanfumey L; Prediger RD; Sepulveda JE; Del-Bel EA; Raisman-Vozari R Neurotox Res; 2016 Apr; 29(3):364-80. PubMed ID: 26403659 [TBL] [Abstract][Full Text] [Related]
16. Benfotiamine protects MPTP-induced Parkinson's disease mouse model via activating Nrf2 signaling pathway. Wang K; Han C; Yang J; Xu W; Wang L; Li H; Wang Y PLoS One; 2024; 19(7):e0307012. PubMed ID: 39042624 [TBL] [Abstract][Full Text] [Related]
17. A role for glia maturation factor dependent activation of mast cells and microglia in MPTP induced dopamine loss and behavioural deficits in mice. Selvakumar GP; Ahmed ME; Thangavel R; Kempuraj D; Dubova I; Raikwar SP; Zaheer S; Iyer SS; Zaheer A Brain Behav Immun; 2020 Jul; 87():429-443. PubMed ID: 31982500 [TBL] [Abstract][Full Text] [Related]
18. Further Characterization of Intrastriatal Lipopolysaccharide Model of Parkinson's Disease in C57BL/6 Mice. Deng I; Corrigan F; Garg S; Zhou XF; Bobrovskaya L Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299000 [TBL] [Abstract][Full Text] [Related]
19. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease. Novikova L; Garris BL; Garris DR; Lau YS Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572 [TBL] [Abstract][Full Text] [Related]
20. Protective role of 6-Hydroxy-1-H-Indazole in an MPTP-induced mouse model of Parkinson's disease. Xiao-Feng L; Wen-Ting Z; Yuan-Yuan X; Chong-Fa L; Lu Z; Jin-Jun R; Wen-Ya W Eur J Pharmacol; 2016 Nov; 791():348-354. PubMed ID: 27614126 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]